Effects of hospital generic drug substitution on diabetes therapy

References

• Bureau of National Health Insurance (BNHI), Taiwan [http://www.nhi.gov.tw/english/index.aspx]Accessed April 2, 2013
   Google Scholar
• LiuYMYangYHHsiehCRRegulation and competition in the Taiwanese pharmaceutical market under national health insuranceJ Health Econ20123147148322525716
   PubMed Web of Science ®Google Scholar
• HaasJSPhillipsKAGerstenbergerEPSegerACPotential savings from substituting generic drugs for brand-name drugs: Medical Expenditure Panel Survey, 1997–2000Ann Intern Med200514289189715941695
   PubMed Web of Science ®Google Scholar
• HolmesCBCogginWJamiesonDUse of generic antiretroviral agents and cost savings in PEPFRA treatment programsJAMA201030431312020639565
   PubMed Web of Science ®Google Scholar
• HelmersSLParadisPEManjunathREconomic burden associated with the use of generic antiepileptic drugs in the United StatesEpilepsy Behav20101843744420580619
   PubMed Web of Science ®Google Scholar
• JohnstonAAsmarRDahlöfBGeneric and therapeutic substitution: a viewpoint on achieving best practice in EuropeBr J Clin Pharmacol201172572773021486316
   PubMed Web of Science ®Google Scholar
• KesselheimASMisonoASLeeJLClinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysisJAMA2008300212514252619050195
   PubMed Web of Science ®Google Scholar
• KalischLMRougheadEEGilbertALBrand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in AustraliaPharmacoepidemiol Drug Saf20081762062518324613
   PubMed Web of Science ®Google Scholar
• ShrankWHCoxERFischerMAMehtaJChoudhryNKPatients’ perceptions of generic medicationsHealth Aff (Millwood)200928254655619276015
   PubMed Web of Science ®Google Scholar
• ShrankWHLibermanJNFischerMAPhysician perceptions about generic drugsAnn Pharmacother201145313821205953
   PubMed Web of Science ®Google Scholar
• DuerdenMGHughesDAGeneric and therapeutic substitutions in the UK: are they a good thing?Br J Clin Pharmacol20107033534120716231
   PubMed Web of Science ®Google Scholar
• AnderssonKBergstromGPetzoldMGCarlstenAImpact of a generic substitution reform on patients’ and society’s expenditure for pharmaceuticalsHealth Policy20078137638416945449
   PubMed Web of Science ®Google Scholar
• FujiiHIiharaHYasudaKEvaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapyMed Oncol201128248849320354823
   PubMed Web of Science ®Google Scholar
• GilmanJTAlvarezLADuchownyMCarbamazepine toxicity resulting from generic substitutionNeurology19934312269626978255480
   PubMed Web of Science ®Google Scholar
• ShawJESicreeRAZimmetPZGlobal estimates of the prevalence of diabetes for 2010 and 2030Diabetes Res Clin Pract20108741419896746
   PubMed Web of Science ®Google Scholar
• AlexanderGCSehgalNLMoloneyRMStaffordRSNational trends in treatment of type 2 diabetes mellitus, 1994–2007Arch Intern Med20081682088209418955637
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationStandards of medical care in diabetesDiabetes Care200427Suppl 1S15S3514693923
   PubMedGoogle Scholar
• SoenaryaSApplication of the ATC/DDD methodology to measure antibiotic utilization for treatment of hospitalized patients with community-acquired pneumonia at an Indonesian hospitalPharm World Sci200931329329
   Google Scholar
• Van WijkBLGKlungelOHHeerdinkERde BoerAGeneric substitution of antihypertensive drugs: does it affect adherence?Ann Pharmacother200640152016303985
   PubMed Web of Science ®Google Scholar
• RodinHAHeatonAHWilsonARGarrettNAPlocherDWPlan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefitAm J Manag Care20091588188820001169
   PubMed Web of Science ®Google Scholar
• DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol1992456136191607900
   PubMed Web of Science ®Google Scholar
• YatesAPLaingIAge-related increase in haemoglobin A1c and fasting plasma glucose is accompanied by a decrease in beta cell function without change in insulin sensitivity: evidence from a cross-sectional study of hospital personnelDiabet Med20021925425811918628
   PubMed Web of Science ®Google Scholar
• HellströmJRudholmNUncertainty in the generic versus brand name prescription decisionEmpir Econ201038503521
   Web of Science ®Google Scholar
• ParaponarisAVergerPDesquinsBDelivering generics without regulatory incentives? Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary namesHealth Policy200470233215312707
   PubMed Web of Science ®Google Scholar
• ChuaGNHassaliMAShafieAAAwaisuAA survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of MalaysiaHealth Policy20109522923520044165
   PubMed Web of Science ®Google Scholar
• TsiantouVZavrasDKousoulakouHGeneric medicines: Greek physicians’ perceptions and prescribing practicesJ Clin Pharm Ther20093454755419744010
   PubMed Web of Science ®Google Scholar
• FernerRELenneyWMarriottJFControversy over generic substitutionBMJ2010340c254820516014
   PubMed Web of Science ®Google Scholar
• WiernspergerNFBaileyCJThe antihyperglycaemic effect of metformin – therapeutic and cellular mechanismsDrugs199958313910576523
   PubMed Web of Science ®Google Scholar
• CharpentierGFleuryFKabirMImproved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patientsDiabet Med20011882883411678974
   PubMed Web of Science ®Google Scholar
• ArechavaletaRSeckTChenYEfficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trialDiabetes Obes Metab20111316016821199268
   PubMed Web of Science ®Google Scholar
• WrightABurdenACPaiseyRBCullCAHolmanRRUK Prospective Diabetes Study GroupSulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)Diabetes Care20022533033611815505
   PubMed Web of Science ®Google Scholar
• OiknineRMooradianADDrug therapy of diabetes in the elderlyBiomed Pharmacother2003575–623123912888259
   PubMed Web of Science ®Google Scholar
• El-KebbiIMCookCBZiemerDCAssociation of younger age with poor glycemic control and obesity in urban African Americans with type 2 diabetesArch Intern Med2003163697512523919
   PubMedGoogle Scholar
• SchectmanJMNadkarniMMVossJDThe association between diabetes metabolic control and drug adherence in an indigent populationDiabetes Care2002251015102112032108
   PubMed Web of Science ®Google Scholar
• PladevallMWilliamsLKPottsLAClinical outcomes and adherence to medications measured by claims data in patients with diabetesDiabetes Care2004272800280515562188
   PubMed Web of Science ®Google Scholar